37 results
Thumbnail

D2.230 - Cross-Reactivity of Cephalosporins in Patients with IgE-Mediated Allergy to Penicillins: A Systematic Review

Thumbnail

D2.231 - The experiences of ferric carboxymaltose desensitization and provocation

Thumbnail

D2.232 - SDRIFE related to generalized corticosteroids’ hypersensitivity: A case report

Thumbnail

D2.233 - Negative predictive value of skin tests with local anaesthetics

Thumbnail

D2.235 - Is an allergy skin test with local anaesthetics necessary? Real life data with 124 patients

Thumbnail

D2.236 - Drug-induced angioedema by racecadotril in a patient treated with angiotensin-converting enzyme inhibitors

Thumbnail

D2.237 - Corticosteroid allergy, hypertryptasemia and renal transplant

Thumbnail

D2.238 - Successful Prevention of Subsequent L-Asparaginase Hypersensitivity in Children through Premedication: A Single-Center Experience

Thumbnail

D2.239 - The First Successful Desensitization in Abemaciclib Hypersensitivity: A Case Report

Thumbnail

D2.242 - Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome in a Romanian University Hospital

Thumbnail

D2.243 - From Risk to Solution: Effective Desensitization in a Confirmed Delayed Hypersensitivity Reaction to Albendazole

Thumbnail

D2.245 - Long-Term Outcomes of Beta-Lactam Allergy De-Labelling: A Retrospective 10 year Analysis of Patient Confidence and Antibiotic Tolerance

Thumbnail

D2.332 - Patients With HAE Report Positive Perceptions Following Berotralstat Treatment: Results from a Focus Group

Thumbnail

D2.325 - Long-Term Safety and Efficacy of Oral Deucrictibant for Treatment of Hereditary Angioedema Attacks: Results of the RAPIDe-2 Extension Study

Thumbnail

D2.326 - Long-Term Safety and Efficacy of Oral Deucrictibant for Prophylaxis in Hereditary Angioedema: Data Snapshot Results of the CHAPTER-1 Open-Label Extension Study

Thumbnail

D2.327 - Outcome of hematopoietic stem cells transplantation for inborn error of immunity in Vietnam

Thumbnail

D2.328 - Comparison of the frequency of viral infections in immunocompromised patients receiving immunoglobulin by different routes

Thumbnail

D2.329 - Impact of Berotralstat on Quality of Life among Patients with Hereditary Angioedema: Pooled Analysis of the APeX-2 and APeX-J Trials

Thumbnail

D2.330 - Hereditary angioedema prophylaxis therapy: berotralstat and lanadelumab safety profile

Thumbnail

D2.331 - Lanadelumab safety and efficacy in patients aged ≥12 with hereditary angioedema (HAE) in China for long-term prophylaxis (LTP): An open-label, multicenter study